Pages that link to "Q35620664"

The following pages link to Clinical relevance of P-glycoprotein in drug therapy (Q35620664):

Displaying 46 items.

• Discovery of 5''-chloro-N-[(5,6-dimethoxypyridin-2-yl)methyl]-2,2':5',3''-terpyridine-3'-carboxamide (MK-1064): a selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia (Q28304842) (← links)
• Diesel exhaust particles induce oxidative stress, proinflammatory signaling, and P-glycoprotein up-regulation at the blood-brain barrier (Q28385084) (← links)
• P-Glycoprotein Transport of Neurotoxic Pesticides (Q28389145) (← links)
• Targeting multidrug resistance in cancer (Q29616803) (← links)
• Recent advances in pharmacokinetic extrapolation from preclinical data to humans (Q31049599) (← links)
• Are transporter genes other than the chloroquine resistance locus (pfcrt) and multidrug resistance gene (pfmdr) associated with antimalarial drug resistance? (Q33836765) (← links)
• Review article: prescribing medications in patients with cirrhosis - a practical guide (Q34342554) (← links)
• Role of Organic Cation Transporter 1, OCT1 in the Pharmacokinetics and Toxicity of cis-Diammine(pyridine)chloroplatinum(II) and Oxaliplatin in Mice (Q34579707) (← links)
• Behavioral effects and central nervous system levels of the broadly available κ-agonist hallucinogen salvinorin A are affected by P-glycoprotein modulation in vivo (Q35996706) (← links)
• New horizon of MDR1 (P-glycoprotein) study (Q36300806) (← links)
• A novel human multidrug resistance gene MDR1 variant G571A (G191R) modulates cancer drug resistance and efflux transport (Q36337509) (← links)
• ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogenetics (Q36441533) (← links)
• Efflux transporters as a novel herbivore countermechanism to plant chemical defenses (Q36505056) (← links)
• Application of pharmacological approaches to plant-mammal interactions. (Q36505065) (← links)
• Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance (Q36582619) (← links)
• Membrane transporter proteins: a challenge for CNS drug development. (Q36659167) (← links)
• Transporter-mediated drug interactions: clinical implications and in vitro assessment (Q36725222) (← links)
• Pharmacogenetics of opioids (Q36752672) (← links)
• Intestinal permeability and its relevance for absorption and elimination (Q36985043) (← links)
• Prediction of human pharmacokinetics-biliary and intestinal clearance and enterohepatic circulation (Q37139856) (← links)
• Schistosoma mansoni P-glycoprotein levels increase in response to praziquantel exposure and correlate with reduced praziquantel susceptibility (Q37223703) (← links)
• Absence of P-glycoprotein transport in the pharmacokinetics and toxicity of the herbicide paraquat. (Q37550693) (← links)
• Evaluation of in vivo P-glycoprotein phenotyping probes: a need for validation (Q37705351) (← links)
• The pharmacology of novel oral anticoagulants (Q38122099) (← links)
• Pharmacogenomics of methadone maintenance treatment (Q38222510) (← links)
• Anticancer agent-based marine natural products and related compounds (Q38307526) (← links)
• Raltegravir has a low propensity to cause clinical drug interactions through inhibition of major drug transporters: an in vitro evaluation (Q38324557) (← links)
• Preclinical absorption, distribution, metabolism, excretion, and pharmacokinetic-pharmacodynamic modelling of N-(4-(3-((3S,4R)-1-ethyl-3-fluoropiperidine-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-4-yloxy)-3-fluorophenyl)-2-(4-fluorophenyl)-3-oxo-2,3-dihy (Q39616531) (← links)
• A novel MDR1 GT1292-3TG (Cys431Leu) genetic variation and its effect on P-glycoprotein biologic functions (Q39681554) (← links)
• Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrier (Q39821262) (← links)
• Simulation and Prediction of the Drug-Drug Interaction Potential of Naloxegol by Physiologically Based Pharmacokinetic Modeling (Q42071305) (← links)
• Effects of the ABCB1 (1199G > A) Polymorphism on Steroid Sex Hormone-Induced P-Glycoprotein Expression, ATPase Activity, and Hormone Efflux (Q42705654) (← links)
• The importance of plasma protein binding in drug discovery (Q43851506) (← links)
• Computational prediction of blood-brain barrier permeability using decision tree induction. (Q45076681) (← links)
• Discovery of a potent, CNS-penetrant orexin receptor antagonist based on an n,n-disubstituted-1,4-diazepane scaffold that promotes sleep in rats. (Q46024144) (← links)
• Effects of dietary flavonoids on the transport of cimetidine via P-glycoprotein and cationic transporters in Caco-2 and LLC-PK1 cell models (Q46296966) (← links)
• Co-delivery of honokiol, a constituent of Magnolia species, in a self-microemulsifying drug delivery system for improved oral transport of lipophilic sirolimus (Q46477608) (← links)
• Vascular endothelium-selective gene induction by Tie2 promoter/enhancer in the brain and retina of a transgenic rat. (Q46538458) (← links)
• The advantages of the Ussing chamber in drug absorption studies (Q46644570) (← links)
• Relationship between ABCB1 polymorphisms and serum methadone concentration in patients undergoing methadone maintenance therapy (MMT). (Q51710092) (← links)
• Effects of silymarin and formulation on the oral bioavailability of paclitaxel in rats (Q53394623) (← links)
• Establishment and Characterization of a Novel Caco-2 Subclone with a Similar Low Expression Level of Human Carboxylesterase 1 to Human Small Intestine. (Q53764228) (← links)
• The discovery of non-benzimidazole and brain-penetrant prolylcarboxypeptidase inhibitors (Q82485613) (← links)
• The relevance of assessment of intestinal P-gp inhibition using digoxin as an in vivo probe substrate (Q83071704) (← links)
• Novel second generation analogs of eribulin. Part II: Orally available and active against resistant tumors in vivo (Q83419379) (← links)
• Applicability of free drug hypothesis to drugs with good membrane permeability that are not efflux transporter substrates: A microdialysis study in rats (Q91718128) (← links)